197 related articles for article (PubMed ID: 35467392)
41. Aqueous chlorhexidine 1% versus 2% for neonatal skin antisepsis: a randomised non-inferiority trial.
Sharma A; Kulkarni S; Thukral A; Sankar MJ; Agarwal R; Deorari AK; Mohapatra S; Velpandian T; Bajpai M
Arch Dis Child Fetal Neonatal Ed; 2021 Nov; 106(6):643-648. PubMed ID: 34108192
[TBL] [Abstract][Full Text] [Related]
42. Effect of skin antiseptic solutions on the incidence of catheter-related bloodstream infection: a systematic review and network meta-analysis.
Masuyama T; Yasuda H; Sanui M; Lefor AK
J Hosp Infect; 2021 Apr; 110():156-164. PubMed ID: 33529623
[TBL] [Abstract][Full Text] [Related]
43. Pre-operative skin antisepsis with chlorhexidine gluconate baths and wipes does not prevent postoperative surgical site infection in outpatient pediatric urologic inguinal and scrotal surgery.
Berrondo C; Ahn JJ; Shnorhavorian M
J Pediatr Urol; 2019 Dec; 15(6):652.e1-652.e7. PubMed ID: 31564588
[TBL] [Abstract][Full Text] [Related]
44. Preliminary analysis of the antimicrobial activity of a postoperative wound dressing containing chlorhexidine gluconate against methicillin-resistant Staphylococcus aureus in an in vivo porcine incisional wound model.
Mana TSC; Donskey C; Carty N; Perry L; Leaper D; Edmiston CE
Am J Infect Control; 2019 Sep; 47(9):1048-1052. PubMed ID: 31277998
[TBL] [Abstract][Full Text] [Related]
45. Randomized, Prospective Study of the Order of Preoperative Preparation Solutions for Patients Undergoing Foot and Ankle Orthopedic Surgery.
Hunter JG; Dawson LK; Soin SP; Baumhauer JF
Foot Ankle Int; 2016 May; 37(5):478-82. PubMed ID: 26678427
[TBL] [Abstract][Full Text] [Related]
46. Development of a New Application for Comprehensive Viability Analysis Based on Microbiome Analysis by Next-Generation Sequencing: Insights into Staphylococcal Carriage in Human Nasal Cavities.
Lu YJ; Sasaki T; Kuwahara-Arai K; Uehara Y; Hiramatsu K
Appl Environ Microbiol; 2018 Jun; 84(11):. PubMed ID: 29625975
[TBL] [Abstract][Full Text] [Related]
47. Is 2% chlorhexidine gluconate in 70% isopropyl alcohol more effective at preventing central venous catheter-related infections than routinely used chlorhexidine gluconate solutions: A pilot multicenter randomized trial (ISRCTN2657745)?
McCann M; Fitzpatrick F; Mellotte G; Clarke M
Am J Infect Control; 2016 Aug; 44(8):948-9. PubMed ID: 27079247
[TBL] [Abstract][Full Text] [Related]
48. Effects of food colouring added to 2% chlorhexidine gluconate and 70% alcohol for surgical site antisepsis.
Chow J; Ng J; Pun A
J Perioper Pract; 2013 Nov; 23(11):255-7. PubMed ID: 24312996
[TBL] [Abstract][Full Text] [Related]
49. Implementing daily chlorhexidine gluconate treatment for the prevention of healthcare-associated infections in non-intensive care settings: A multiple case analysis.
Musuuza JS; Roberts TJ; Hundt AS; Carayon P; Zimbric ML; Schuetz V; Reppen M; Smith W; Koffarnus K; Brown RL; Bowling J; Jalali K; Safdar N
PLoS One; 2020; 15(4):e0232062. PubMed ID: 32330165
[TBL] [Abstract][Full Text] [Related]
50. Safety and efficacy of 2% chlorhexidine gluconate aqueous versus 2% chlorhexidine gluconate in 70% isopropyl alcohol for skin disinfection prior to percutaneous central venous catheter insertion in preterm neonates: the ARCTIC randomised-controlled feasibility trial protocol.
Clarke P; Craig JV; Wain J; Tremlett C; Linsell L; Bowler U; Juszczak E; Heath PT
BMJ Open; 2019 Feb; 9(2):e028022. PubMed ID: 30782955
[TBL] [Abstract][Full Text] [Related]
51. Analysis of chlorhexidine gluconate in skin using tape stripping and ultrahigh-performance liquid chromatography-tandem mass spectrometry.
Zhao X; Schaffzin JK; Carson J; Ankrum A; Dobrzykowski E; Haslam DB; Dandoy CE; Setchell KDR
J Pharm Biomed Anal; 2020 May; 183():113111. PubMed ID: 32062012
[TBL] [Abstract][Full Text] [Related]
52. The impact of chlorhexidine bathing on hospital-acquired bloodstream infections: a systematic review and meta-analysis.
Musuuza JS; Guru PK; O'Horo JC; Bongiorno CM; Korobkin MA; Gangnon RE; Safdar N
BMC Infect Dis; 2019 May; 19(1):416. PubMed ID: 31088521
[TBL] [Abstract][Full Text] [Related]
53. Evidence for the effectiveness of chlorhexidine bathing and health care-associated infections among adult intensive care patients: a trial sequential meta-analysis.
Frost SA; Hou YC; Lombardo L; Metcalfe L; Lynch JM; Hunt L; Alexandrou E; Brennan K; Sanchez D; Aneman A; Christensen M
BMC Infect Dis; 2018 Dec; 18(1):679. PubMed ID: 30567493
[TBL] [Abstract][Full Text] [Related]
54. Chlorhexidine-impregnated sponge versus chlorhexidine gel dressing for short-term intravascular catheters: which one is better?
Buetti N; Ruckly S; Schwebel C; Mimoz O; Souweine B; Lucet JC; Timsit JF
Crit Care; 2020 Jul; 24(1):458. PubMed ID: 32703235
[TBL] [Abstract][Full Text] [Related]
55. Chlorhexidine Gluconate Utilization for Infection Prevention in the NICU: A Survey of Current Practice.
Beekman K; Steward D
Adv Neonatal Care; 2020 Feb; 20(1):38-47. PubMed ID: 31567183
[TBL] [Abstract][Full Text] [Related]
56. Bathing With 2% Chlorhexidine Gluconate: Evidence and Costs Associated With Central Line-Associated Bloodstream Infections.
Shah HN; Schwartz JL; Luna G; Cullen DL
Crit Care Nurs Q; 2016; 39(1):42-50. PubMed ID: 26633158
[TBL] [Abstract][Full Text] [Related]
57. Tegaderm™ CHG dressing significantly improves catheter-related infection rate in hemodialysis patients.
Righetti M; Palmieri N; Bracchi O; Prencipe M; Bruschetta E; Colombo F; Brenna I; Stefani F; Amar K; Scalia A; Conte F
J Vasc Access; 2016 Sep; 17(5):417-422. PubMed ID: 27516139
[TBL] [Abstract][Full Text] [Related]
58. Optimisation of methods for bacterial skin microbiome investigation: primer selection and comparison of the 454 versus MiSeq platform.
Castelino M; Eyre S; Moat J; Fox G; Martin P; Ho P; Upton M; Barton A
BMC Microbiol; 2017 Jan; 17(1):23. PubMed ID: 28109256
[TBL] [Abstract][Full Text] [Related]
59. Impact of 1% chlorhexidine gluconate bathing and emollient application on bacterial pathogen colonization dynamics in hospitalized preterm neonates - A pilot clinical trial.
Dramowski A; Pillay S; Bekker A; Abrahams I; Cotton MF; Coffin SE; Whitelaw AC
EClinicalMedicine; 2021 Jul; 37():100946. PubMed ID: 34195575
[TBL] [Abstract][Full Text] [Related]
60. Reducing the risk of surgical site infections: does chlorhexidine gluconate provide a risk reduction benefit?
Edmiston CE; Bruden B; Rucinski MC; Henen C; Graham MB; Lewis BL
Am J Infect Control; 2013 May; 41(5 Suppl):S49-55. PubMed ID: 23622749
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
